LINDSEY KOKANOVICH: Open Payments
NPI 1144779307 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 27 payments from 9 companies in 2025. Trend: 2023 $67 · 2024 $322 · 2025 $783
Food & beverage: $766Education: $16
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 6 | $168 |
| Tandem Diabetes Care, Inc. | 8 | $159 |
| Sequel Med Tech, LLC | 2 | $151 |
| Medtronic, Inc. | 3 | $141 |
| Novo Nordisk Inc | 4 | $77 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
Products named: iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, TWIIST, MINIMED 780G, Ozempic, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Yorvipath.
Industry payments across VA — which companies pay providers there.
